Zobkiw, L, “Studies Demonstrate Significant Anti-tumor Activity Against Human Myeloma and Lymphoma Tumors in Mice; In Vivo Data Add to Growing Evidence of Tolomerase Inhibition as a Potential Treatment for Cancer,” Press Release, Geron Corporation, Menlo Park, CA, Jun. 13, 2002, four page document.* |
Shea-Herbert et al., “Oligonucleotide N3′->P5′ Phosphoramidates as Efficient Telomerase Inhibitors,” Oncogene, 21, 638-642 (2002).* |
Glukhov et al., “Inhibition of Telomerase Activity of Melanoma Cells In Vitro by Antisense Oligonucleotides,” Biochemical and Biophysical Research Communications, 248(2), 368-371 (Jul. 20, 1998).* |
Pitts et al., “Inhibition of Human Telomerase by 2′-O-methyl-RNA,” Proceeding of the National Academy of Sciences USA, 95, 11549-11554 (Sep. 29, 1998).* |
Tao et al. (I), “Specific Inhibition of Human Telomerase Activity by Transfection Reagent, FuGENE6-Antisense Phosphorothioate Oligonucleotide Complex in HeLa Cells,” FEBS Letters, 454(3), 312-316 (Jul. 9, 1999).* |
Tao et al. (II), “Inhibition of Telomerase Activity of Antisense Oligo-nucleotides in HeLa Cells,” Twentyfifth Symp. on Nucleic Acids Chemistry, Nucleic Acids Symposium Series, No. 39, pp. 85-86, Sugitomo et al. (eds.), Oxford University Press, Kobe, Japan, Sep. 18-20, 1998.* |
Gryaznov, S., et al.., “Oligonucleotides N3′→P5′ Phosphoramidates As Antisense Agents”, Nucleic Acids Res., 24(8):1508-1514 (1996), (Apr. 15, 1996). |
Hamilton, S., et al., “Cellular Delivery of Peptide Nucleic Acids and Inhibition of Human Telomerase”, Chemistry & Biology, 6:343-351 (May 12, 1999). |
Kers, I., et al., “A New Synthetic Method for the Preparation of Nucleoside Phosphoramidate Analogues with the Nitrogen Atom in Bridging Positions of the Phosphoramidate Linkage”, Tetrahedron Ltrs., 39:1219-1222 (1998). |
Mignet, N., et al., “Zwitterionic Oligodeoxyribonucleotide N3′→P5′ Phosphoramidates: Synthesis and Properties”, Nucleic Acids Research, 26(2):431 (1998), (Issue No. 2). |
Ohnuma, T., et al., “Inhibitory Effects of Telomere-Mimic Phosphorothioate Oligonucleotides on Various Human Tumor Cells In Vitro”, Anticancer Research, 17:2455-2458 (1997). |
Testa, S., et al., “In Vitro Suicide Inhibition of Self-Splicing of a Group I Intron from Pneumocystis Carinii by An N3′→P5′ Phosphoramidate Hexanucleotide”, Proc. Natl. Acad. Sci. USA, 96:2734 (Mar., 1999). |
Wagner, R., “Gene Inhibition Using Antisense Oligodeoxynucleotides”, Nature, 372:333 (Nov. 24, 1994). |
Corey DR, et al., Telomerase inhibition, oligonucleotides, and clinical trials, Oncogene 21:631 (2002). |
Folini M, et al., Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells, J Invest Dermatol. 114:259 (Feb. 2, 2000). |
Harrison, J, et al., Inhibitionof Human Telomerase by PNA-Cationic Peptide Conjugates, Bioorganic & Med Chem Letters 9:1273 (1999). |
Komata T, Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53, Gene Ther. 7:2071 (2000). |
Matthes, et al., Telomerase Protein Rather Than Its RNA is the Target of Phosphorothioate-Modified Oligonucleotides, Nucleic Acids Res. 27:1152 (1999). |
Muller A, et al., Telomerase inhibition by induced expression of antisense RNA, Adv Exp Med Biol. 451:23 (1998). |
Saeki T, et al., Inhibitory Effect of Telomere-Mimic Phosphorothioate Oligodeoxy Nucleotides (S-ODNS) on Human Tumor Cell Lines, Oncology 57:27 (Suppl 2) (1999). |
Saretzki G, et al., Ribozyme-mediated telomerase inhibition induces immediate cell lose but not telomerase shortening in ovarian cancer cells, Cancer Gene Ther. 8:827 (2001). |
Schindler A, et al., Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitro, Int J Oncol. 19:25 (2001). |
Shae-Herbert, et al., Oligonucleotide N3′-P5′ phosphoramidates as efficient telomerase inhibitors, Oncogene 21:638 (2002). |
Shammas M, et al., Telomerase inhibition by peptide nucleic acids reverse ‘immortality’ of transformed human cells, Oncogene 18:6191 (1999). |
Tamura, Y, et al., Inhibition of Human Telomerase Activity by Antisense Phosphorothioate Oligonucleotides Encapsulated with the Transfection Reagent, FuGENE™6, in HeLa Cells, Antisense & Nucleic Acid Drug Dev 10:87 (2000). |
Tao M, et al., Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells, FEBS Lett. 454:312 (1999). |
Villa R, et al., Inhibition of telomerase activity by a cell-penetrating peptide nucleic acit construct in human melanoma cells, FEBS Letters 473:241 (2000). |
von Janta-Lipinski, et al., Protein and RNA of Human Telomerase as Targets for Modified Oligonucleotides, Nucleotides & Nucleotides 18:1719 (1999), (Issue No. 6-7). |